Okay, “myelo” means bone marrow. Since multiple myeloma is a blood cancer that grows in your bone marrow-that make sense.
But why is it called MULTIPLE Myeloma anyway!? The answer goes to how MM can manifest itself inside you.There is such as thing as single myeloma. It is called a single or solitary plasmacytoma.
When I was first diagnosed in early ’94 the x-ray showed a large mass in my neck. Eight hours of surgery determined that the mass was a single plasmacytoma.
If I knew then what I know now I would have jumped on the many evidence-based, non-toxic, anti-MM therapies that comprise the Multiple Myeloma Cancer Coaching Program (MM CC). Maybe I would have remained in a pre-MM stage.
If you are a newly diagnosed MMer is it important to understand that pre-MM is not full-blown MM. MGUS, SMM and single plasmcytomas are pre-MM stages that may not become MM for years if ever. Your challenge is that conventional oncology says that there is nothing you can do. Conventional oncology also says that MM is incurable.
My experience is otherwise.
I have remained in complete remission from my multiple myeloma since 1999. I do this by living an evidence-based, anti-MM lifestyle. I consider my lifestyle to be a non-toxic form of low-dose maintenance therapy coupled with non-t0xic, metronomic therapy.
I have relied on research-based therapies to do so including anti-MM nutrition, anti-MM supplementation, anti-cancer lifestyle therapies, conventional and non-conventional bone health therapies and mind body therapies. I have created a Multiple Myeloma Cancer Coaching Package, which outlines the evidence-based therapies that I follow.
Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.
Scroll down the page and post a question or a comment is you would like to. I will reply to you ASAP.
“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”
A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.
I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.
The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.
The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.
“CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.“
“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.
The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.
Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.
Based on the published reports,
exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”
According to Consumerlab.com:
“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”